Literature DB >> 31388284

Recurrent Arterial and Venous Thrombosis in Chronic Immune Thrombocytopenia: Clinical Paradox and Therapeutic Challenges.

Ankur Jain1, Sumita Saluja1, Sumita Chaudhry1, D K Gupta1.   

Abstract

Entities:  

Year:  2019        PMID： 31388284      PMCID： PMC6646481          DOI： 10.1007/s12288-019-01136-3

Source DB:  PubMed          Journal:  Indian J Hematol Blood Transfus        ISSN： 0971-4502            Impact factor:   0.900


× No keyword cloud information.
  10 in total

1.  Immune thrombocytopenia - in defence of the platelet count.

Authors:  Quentin A Hill
Journal:  Br J Haematol       Date:  2017-05-08       Impact factor: 6.998

2.  Characteristics, risk factors and management of venous thromboembolism in immune thrombocytopenia: a retrospective multicentre study.

Authors:  Guillaume Le Guenno; Romain Guieze; Sylvain Audia; Mehdi Khellaf; Marc Michel; Bernard Bonnotte; Marc Ruivard; Bertrand Godeau
Journal:  Intern Med J       Date:  2019-09       Impact factor: 2.048

Review 3.  A Seeming Paradox: Ischemic Stroke in the Context of Idiopathic Thrombocytopenic Purpura.

Authors:  Ján Mihalov; Gabriela Timárová
Journal:  Clin Appl Thromb Hemost       Date:  2014-08-12       Impact factor: 2.389

4.  Thrombophilia in patients with chronic immune thrombocytopenia.

Authors:  Raymond S M Wong; Kalpana Bakshi; Andres Brainsky
Journal:  Scand J Clin Lab Invest       Date:  2014-10-09       Impact factor: 1.713

5.  Rebalanced hemostasis in patients with idiopathic thrombocytopenic purpura.

Authors:  Won Ho Kim; Jung Bo Park; Chul Won Jung; Gaab Soo Kim
Journal:  Platelets       Date:  2014-01-16       Impact factor: 3.862

6.  Recurrent ischemic stroke in a patient with idiopathic thrombocytopenic purpura.

Authors:  Hak Young Rhee; Hye-Yeon Choi; Sang-Beom Kim; Won-Chul Shin
Journal:  J Thromb Thrombolysis       Date:  2010-08       Impact factor: 2.300

7.  Management of antithrombotic therapy in adults with immune thrombocytopenia (ITP): a survey of ITP specialists and general hematologist-oncologists.

Authors:  Allyson M Pishko; Mudi Misgav; Adam Cuker; Douglas B Cines; James N George; Sara K Vesely; Deirdra R Terrell
Journal:  J Thromb Thrombolysis       Date:  2018-07       Impact factor: 2.300

Review 8.  Is ITP a thrombophilic disorder?

Authors:  Francesco Rodeghiero
Journal:  Am J Hematol       Date:  2015-11-26       Impact factor: 10.047

Review 9.  Multifocal avascular necrosis in a patient with refractory immune thrombocytopenia and antiphospholipid antibodies; case report and review of literature.

Authors:  Hala El-Gendy; Rasmia M El-Gohary; Safaa Mahfouz; Hamdy M A Ahmed; Doaa M El Demerdash; Gaafar Ragab
Journal:  Platelets       Date:  2018-10-29       Impact factor: 3.862

10.  Vertebral Artery Thrombosis in Chronic Idiopathic Thrombocytopenic Purpura.

Authors:  Zakaria Hindi; Nirmal Onteddu; Christopher A Ching; Abdallah A Khaled
Journal:  Case Rep Hematol       Date:  2017-06-11
  10 in total
  2 in total

1.  Pulmonary Thromboembolism in Immune Thrombocytopenia: A Report of Five Cases and a Review of the Literature.

Authors:  Yong Tan; Min Yan; Zhen Cheng; Xiangtao Pan
Journal:  Int J Gen Med       Date:  2021-08-13

Review 2.  Immune Thrombocytopenic Purpura as a Hemorrhagic Versus Thrombotic Disease: An Updated Insight into Pathophysiological Mechanisms.

Authors:  Claudia Cristina Tărniceriu; Loredana Liliana Hurjui; Irina Daniela Florea; Ion Hurjui; Irina Gradinaru; Daniela Maria Tanase; Carmen Delianu; Anca Haisan; Ludmila Lozneanu
Journal:  Medicina (Kaunas)       Date:  2022-02-01       Impact factor: 2.430
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.